Medical Technology

Hologic, Inc. (NASDAQ:HOLX) reported better-than-expected first-quarter financial results after the bell Thursday. Here's a look at the highlights.  The Details: Hologic reported quarterly adjusted earnings of 98 cents per share, beating the analyst consensus estimate of 95 cents by 3.16% and...

Industry giant Morgan Stanley (NYSE:MS) is shaking up its model for income-focused investors, indicating a strategic move towards robust and resilient players. The multinational investment bank told investors Thursday that it added new positions and adjusted weights in its dividend portfolio. What...

Cathie Wood’s Ark Investment Management on Friday bought 26,126 shares — estimated to be worth $163,026 — in Quantum-Si Inc (NASDAQ: QSI). Shares of the medical technology company closed 6.12% higher at $6.24 a share. The stock is down 40.5% year-to-date. Ark Invest has been...

Johnson & Johnson's (NYSE: JNJ) Vision segment has won FDA approval for the first contact lenses designed to reshape the cornea curve and help treat the progression of myopia in children. Designed to be worn overnight, the Acuvue Abiliti orthokeratology lenses are...

ICAD Inc (NASDAQ: ICAD) is poised to benefit in the long term from its AI-driven cancer detection tools and electronic brachytherapy product, according to BTIG. The iCAD Analyst: Marie Thibault initiated coverage of iCAD with a Buy rating and a price target of $25. The iCAD Thesis: The company...

Silk Road Medical Inc will hit the Nasdaq under ticker SILK on Thursday. Here’s what you should know before making a bid. The Offering Silk Road said it would issue nearly 4.7 million shares between $15 and $17. The offering represents 16.3 percent of outstanding shares. Late Wednesday, the...

Shares of medical technology company Medtronic PLC (NYSE: MDT) were flirting with the $100 per share mark for parts of 2018, but have since come down to a level that should be taken advantage of by investors, according to BTIG. The Analyst Analyst Sean Lavin upgraded Medtronic from...

Neuronetics Inc (NASDAQ: STIM) boasts a therapy that addresses a pressing medical need, according to JMP Securities.  The Analyst Analyst David Turkaly initiated coverage of Neuronetics with an Outperform rating and $36 price target. The Thesis For patients who have failed one of...

After doubling in value over the past seven months alone, shares of Tactile Systems Technology Inc (NASDAQ: TCMD) are trading at a "stretched" valuation despite expectations for continued growth ahead, according to BTIG. The Analyst BTIG's Sean Lavin downgraded Tactile Systems...

Hologic, Inc. (NASDAQ: HOLX) reported fiscal second-quarter results that prompted Leerink to drop its bullish stance on the women's health-focused medical technology company.  The Analyst Leerink's Richard Newitter downgraded Hologic's stock rating from Outperform to Market...

Medtech name IRhythm Technologies Inc (NASDAQ: IRTC) is redefining how cardiac arrhythmias are monitored, which makes the stock an attractive buy, according to BMO Capital Markets.  The Analyst BMO analyst Joanne Wuensch initiated coverage of iRhythm Technologies' stock with an...

Abbott Laboratories (NYSE: ABT) reported fourth-quarter results that were highlighted by a top- and bottom-line beat and a guidance range for the first quarter that came in ahead of the consensus estimate. The Analyst William Blair's Margaret Kaczor upgraded Abbott Laboratories...

Abbott Laboratories (NYSE: ABT) had a busy 2017 after acquiring Alere and St. Jude Medical, earning the stock a nod of approval from a Wall Street analyst. The Analyst BMO Capital Markets' Joanne Wuensch upgraded Abbott's stock rating from Market Perform to Outperform with a price target...

Investors and traders are waking up to the first full trading week of 2017 with a handful of companies issuing preliminary guidance. Given the wide range of market capitalization sizes and completely different industries the companies operate in, it would be difficult to make the case for any macro...